Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis

ClinicalTrials.gov ID: NCT00941486

Public ClinicalTrials.gov record NCT00941486. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Masked, Vehicle-controlled Clinical Trial to Assess the Safety and Efficacy of PVP-I (0.4%)/Dexamethasone (0.1%) Ophthalmic Suspension (Foresight Biotherapeutics, Inc) in the Treatment of Acute Adenoviral Conjunctivitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the efficacy of FST-100 (PVP-I 0.4% and dexamethasone 0.1%) Ophthalmic Suspension in the treatment of suspected acute adenoviral conjunctivitis.

Study identification

NCT ID
NCT00941486
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Shire
Industry
Enrollment
30 participants

Conditions and interventions

Eligibility (public fields only)

Age range
3 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2009 (Actual)
Primary completion
Jun 30, 2010 (Actual)
Completion
Jun 30, 2010 (Actual)
Last update posted
Aug 24, 2021

2009 – 2010

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
Wolstan and Goldberg Eye Associates Torrance California 90505 —
Colorado Eye Associates Colorado Springs Colorado 80907 —
Eye Center Hamden Connecticut 06518 —
The Center for Excellence in Eye Miami Florida 33176 —
Ocean Ophthalmology North Miami Beach Florida 33179 —
The Midwest Center for Sight Des Plaines Illinois 60016 —
Not listed Hoffman Estates Illinois 60169 —
Silverstein Eye Centers Kansas City Missouri 64133 —
St. Johns Clinic Springfield Missouri 65804 —
Ophthalmic Consultants PC The New York Eye and Ear Infirmary New York New York 10003 —
Not listed Wantagh New York 11793 —
Not listed Charlotte North Carolina 28204 —
Columbus Ophthalmology Associates Columbus Ohio 43213 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00941486, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 24, 2021 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00941486 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →